| 32.54 Data as of Jun 18 |  +1.11 / +3.53%Today’s Change | 12.56 Today|||52-Week Range 33.86 | +56.89% Year-to-Date |
| Previous close | 31.43 |
| Today’s open | 31.44 |
| Day’s range | 30.87 - 32.83 |
| Volume | 144,379 |
| Average volume (3 months) | 176,472 |
| Market cap | $636.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -125.90% |
| Earnings growth (this year) | +1,080.00% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +4.50% |
| P/E ratio | NM |
| Price/Sales | 13.12 |
| Price/Book | 23.92 |
| Today’s change | Today’s % change | |
|---|---|---|
| AVNRAvanir Pharmaceutica... | +0.10 | +2.10% |
| MACKMerrimack Pharmaceut... | +0.01 | +0.16% |
| CBPOChina Biologic Produ... | +0.67 | +2.95% |
| ARRYArray Biopharma Inc | -0.13 | -2.55% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | $0.03 |
| Annual revenue (last year) | $31.4M |
| Annual profit (last year) | -$2.7M |
| Net profit margin | -8.52% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director John L. Higgins |
Chief Operating Officer & Executive Vice President Matthew W. Foehr |
Corporate headquarters La Jolla, California |
.
